光学前臨床イメージング市場規模、シェア、成長分析：製品別、最終用途別、地域別 - 産業予測 2025～2032年

光学前臨床イメージング市場規模は2023年に6億2,530万米ドルとなり、予測期間（2025-2032年）のCAGRは4.5%で、2024年の6億5,340万米ドルから2032年には9億2,930万米ドルに成長する見通しです。

世界の光学前臨床イメージング市場は、製薬・バイオテクノロジー分野の研究開発活動の活発化、個別化医療への注目の高まり、前臨床研究における疾患の早期発見の必要性などを背景に、顕著な成長を遂げています。生物発光や蛍光イメージングのような治療技術は、生物学的プロセスの非侵襲的で高解像度の可視化を可能にし、病気の進行をモニターし、治療効果を評価する研究者の能力を向上させる。このような進歩にもかかわらず、この市場は、イメージングシステムの高コストや研究における動物使用に関する倫理的懸念などの課題に直面しています。高度な画像診断機器に関連する費用は、小規模な研究機関にとっては障壁となり、普及を制限する可能性があります。さらに、動物実験をめぐる倫理的配慮から、監視の目が厳しくなり、別の調査方法を求める声が高まっています。技術革新は市場情勢を形成し続けています。新規イメージング薬剤の開発とイメージングシステムへの人工知能（AI）の統合により、画像解析と解釈が強化され、前臨床研究の精度と効率が向上しています。さらに、学術研究機関の世界の拡大も、市場力学の発展に寄与しています。サマリー：光学前臨床イメージング市場は、技術の進歩や研究活動の活発化により成長に向かっていますが、持続可能な開発のためには、高額な機器コストや倫理的懸念などの課題に対処することが不可欠です。継続的な技術革新と研究インフラの拡大が、今後数年の市場の軌道にさらなる影響を与えると予想されます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

光学前臨床イメージング市場規模：製品別& CAGR（2025-2032）

• 市場概要
• デバイス
  • 蛍光
  • 生物発光
• 消耗品
  • 蛍光
  • 緑色蛍光タンパク質
  • 赤色蛍光タンパク質
  • 赤外線染料
  • その他の蛍光
  • 生物発光
  • ルシフェリン
  • プロルシフェリン
  • セレンテラジン
  • その他の生物発光
• ソフトウェア

光学前臨床イメージング市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 製薬・バイオテクノロジー企業
• 調査機関
• その他

光学前臨床イメージング市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Bruker Corporation（USA）
• MR Solutions（UK）
• BioTek Instruments, Inc.（USA）
• MILabs B.V.（Netherlands）
• Magnetic Insight, Inc.（USA）
• MBF Bioscience（USA）
• FUJIFILM Corporation（Japan）
• Mediso Ltd.（Hungary）
• LI-COR Biosciences, Inc.（USA）
• Siemens Healthineers（Germany）
• General Electric（GE）Healthcare（USA）
• Thorlabs, Inc.（USA）
• Carl Zeiss AG（Germany）
• Olympus Corporation（Japan）
• Hamamatsu Photonics K.K.（Japan）
• Berthold Technologies GmbH & Co.KG（Germany）
• Endress+Hauser（Analytik Jena US LLC）（Germany/USA）
• TriFoil Imaging（USA）
• Vieworks Co., Ltd.（South Korea）

結論と提言

Optical Preclinical Imaging Market size was valued at USD 625.3 Million in 2023 and is poised to grow from USD 653.4 Million in 2024 to USD 929.3 Million by 2032, growing at a CAGR of 4.5% during the forecast period (2025-2032).

The global optical preclinical imaging market has experienced notable growth, driven by increased research and development activities in the pharmaceutical and biotechnology sectors, a heightened focus on personalized medicine, and the necessity for early disease detection in preclinical studies. Techniques such as bioluminescence and fluorescence imaging enable non-invasive, high-resolution visualization of biological processes, enhancing researchers' ability to monitor disease progression and assess treatment efficacy. Despite these advancements, the market faces challenges, including the high cost of imaging systems and ethical concerns regarding animal use in research. The expense associated with advanced imaging equipment can be a barrier for smaller research institutions, potentially limiting widespread adoption. Additionally, ethical considerations surrounding animal testing have led to increased scrutiny and calls for alternative research methods. Technological innovations continue to shape the market landscape. The development of novel imaging agents and the integration of artificial intelligence (AI) in imaging systems are enhancing image analysis and interpretation, thereby improving the accuracy and efficiency of preclinical studies. Moreover, the expansion of academic and research institutions globally contributes to the evolving dynamics of the optical preclinical imaging market. In summary, while the optical preclinical imaging market is poised for growth due to technological advancements and increased research activities, addressing challenges such as high equipment costs and ethical concerns is essential for sustainable development. Ongoing innovations and the expansion of research infrastructures are expected to further influence the market's trajectory in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Optical Preclinical Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Optical Preclinical Imaging Market Segments Analysis

Global Optical Preclinical Imaging Market is segmented by Product, End Use and region. Based on Product, the market is segmented into Device, Consumables and Software. Based on End Use, the market is segmented into Pharma and Biotech Companies, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Optical Preclinical Imaging Market

The increasing demand for advanced imaging technologies in preclinical research within the pharmaceutical and biotechnology sectors has led to the adoption of optical imaging techniques, such as bioluminescence and fluorescence imaging. These methods offer non-invasive, high-resolution visualization of biological processes, providing researchers with valuable insights into disease progression and treatment efficacy. By enabling real-time monitoring of molecular and cellular activities in living organisms, optical imaging enhances the understanding of disease mechanisms and accelerates the development of targeted therapies.

Restraints in the Optical Preclinical Imaging Market

The high cost of advanced preclinical imaging systems poses a significant barrier, particularly for smaller research institutions and organizations with limited budgets. These sophisticated technologies require substantial capital investment and technical expertise, making them less accessible to entities with financial constraints. Additionally, ethical concerns regarding the use of animals in preclinical research present challenges. Researchers are increasingly encouraged to justify the necessity of animal experiments and to adhere to stringent ethical guidelines, which may involve exploring alternative methods or reducing animal usage. These factors collectively impact the adoption and implementation of advanced imaging technologies in preclinical studies.

Market Trends of the Optical Preclinical Imaging Market

The preclinical imaging field is increasingly emphasizing multimodal approaches, integrating various optical imaging techniques to obtain comprehensive and complementary data. This strategy enhances the depth and precision of studies by combining the strengths of different modalities. For instance, combining optical imaging with other modalities like MRI or PET provides both functional and anatomical information, offering a more holistic understanding of biological processes. Concurrent advancements in imaging agents, such as fluorescent probes and bioluminescent markers, have further refined visualization capabilities. Developments in fluorescence imaging probes have resulted in brighter contrast agents detectable at extremely low concentrations, enhancing sensitivity and specificity. These innovations collectively contribute to more detailed and accurate preclinical studies, facilitating a deeper understanding of disease mechanisms and the development of targeted therapies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Optical Preclinical Imaging Market Size by Product & CAGR (2025-2032)

• Market Overview
• Device
  • Fluorescence
  • Bioluminescence
• Consumables
  • Fluorescence
  • Green Fluorescent Proteins
  • Red Fluorescent Proteins
  • Infrared Dyes
  • Others
  • Bioluminescence
  • Luciferins
  • Proluciferins
  • Coelenterazine
  • Others
• Software

Global Optical Preclinical Imaging Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Pharma and Biotech Companies
• Research Institutes
• Others

Global Optical Preclinical Imaging Market Size & CAGR (2025-2032)

• North America (Product, End Use)
  • US
  • Canada
• Europe (Product, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MR Solutions (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTek Instruments, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MILabs B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Magnetic Insight, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MBF Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LI-COR Biosciences, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric (GE) Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thorlabs, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamamatsu Photonics K.K. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berthold Technologies GmbH & Co.KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endress+Hauser (Analytik Jena US LLC) (Germany/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TriFoil Imaging (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vieworks Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations